SLXN as of Nov 5 · 05:04 ET
SLXNNasdaqBiological Products, (No Diagnostic Substances)
Silexion Therapeutics Corp · Brief
Next report
6 days
Nov 11 · before openest.Q3 FY26
Expected move
No implied move.
—≥ implied
Q2 FY26—▼−8.65%—
quarterimplied−10%0+10%realized×
Q2 FY26—▼−8.65%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 11 report · est.—
Linked exposure
SLXN report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.